The oncometabolite and enantiomer of L-2-HG, D-2-HG, is produced in cancer cells with isocitrate dehydrogenase (IDH) 1 and 2 mutations, including AML,42 with profound effects on hematopoiesis.43 This evidence concerns the gene IDH3A and acute myeloid leukemia.